Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Ryanodine
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Ryanodine

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

A methylpyrrole-carboxylate from ryania that disrupts the ryanodine receptor calcium release channel to modify calcium release from sarcoplasmic reticulum resulting in alteration of muscle contraction.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (846 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A methylpyrrole-carboxylate from ryania that disrupts the ryanodine receptor calcium release channel to modify calcium release from sarcoplasmic reticulum resulting in alteration of muscle contraction. It was previously used in insecticides. It is used experimentally in conjunction with thapsigargin and other inhibitors of calcium atpase uptake of calcium into sarcoplasmic reticulum.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Where it fits in the MeSH classification

Broader topics
Diterpenes; Alkaloids; Pyrroles

Related concepts

  • Ryania
  • Ryanodine Receptor Calcium Release Channel
  • Calcium
  • Sarcoplasmic Reticulum
  • Muscle Contraction
  • Insecticides
  • Thapsigargin
  • Calcium Atpase

Research landscape

PubMed indexes 2,915 records tagged with the MeSH heading “Ryanodine” (counts retrieved 2026-10-31). 57 of them (2.0%) were published from 2020 onward, and the busiest period so far is through 1999 with 1,669 records.

Reviews account for 63 records (2.2%) and meta-analyses for 0. Randomized controlled trials number 0 (0.0%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 1,669 records; 2000-2009: 935 records; 2010-2019: 254 records; 2020 onward: 57 records1,669through 19999352000-20092542010-2019572020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19991,669
2000-2009935
2010-2019254
2020 onward57
Share of records by publication typeReviews: 2.2 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.0 percentReviews2.2% (63)Meta-analyses0.0% (0)Randomized controlled trials0.0% (0)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 2,915 PubMed records
TypeRecordsShare
Reviews632.2%
Meta-analyses00.0%
Randomized controlled trials00.0%

Method: PubMed query "Ryanodine"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Structural and functional remodeling of the atrioventricular node with aging in rats: The role of hyperpolarization-activated cyclic nucleotide-gated and ryanodine 2 channels
Saeed Y, Temple IP, Borbas Z, Atkinson A, Yanni J, Maczewski M, et al.
2018Research article
Design not recorded in structured metadata
27cc by
PMID 29288034 · DOI · PMC5934612
The role of calcium stores in long-term potentiation and synaptic tagging and capture in mouse hippocampus
Koek LA, Sanderson TM, Georgiou J, Collingridge GL
2024Research article
Design not recorded in structured metadata
12cc by
PMID 38853556 · DOI · PMC11343308
Identification of an amino-terminus determinant critical for ryanodine receptor/Ca2+ release channel function
Seidel M, de Meritens CR, Johnson L, Parthimos D, Bannister M, Thomas NL, et al.
2021Research article
Design not recorded in structured metadata
11cc by
PMID 32077934 · DOI · PMC7898959
Ryanodine-1-Calstabin Complex Stabilizers in Antidoping Research: Synthesis, Metabolism, and Characterization
Möller T, Piper T, Thevis M
2026Research article
Design not recorded in structured metadata
1cc by
PMID 41454756 · DOI · PMC12743319

Structural and functional remodeling of the atrioventricular node with aging in rats: The role of hyperpolarization-activated cyclic nucleotide-gated and ryanodine 2 channels [1]

Research article Saeed Y, Temple IP, Borbas Z, Atkinson A, Yanni J, Maczewski M, et al. · · 2018 · cited 27 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundAging is associated with an increased incidence of atrioventricular nodal (AVN) dysfunction.
Closing excerpt
For the first time, we have shown that HCN and RyR2 play an important role in AVN dysfunction with aging.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (221 words)

BackgroundAging is associated with an increased incidence of atrioventricular nodal (AVN) dysfunction.ObjectiveThe aim of this study was to investigate the structural and functional remodeling in the atrioventricular junction (AVJ) with aging.MethodsElectrophysiology, histology, and immunohistochemistry experiments on male Wistar Hannover rats aged 3 months (n = 24) and 2 years (n = 15) were performed. Atrio-His (AH) interval, Wenkebach cycle length (WBCL), and AVN effective refractory period (AVNERP) were measured. Cesium (2 mM) was used to block hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, while ryanodine (2 μM) was used to block ryanodine 2 (RyR2) channels. Protein expression from different regions of the AVJ was studied using immunofluorescence. The expression of connexins (connexin 43 and connexin 40), ion channels (Hyperpolarization-activated cyclic nucleotide-gated channel 4 (HCN4), voltage sensitive sodium channel (Nav1.5), and L-Type calcium channel (Cav1.3)), and calcium handling proteins (RyR2 and sarco/endoplasmic reticulum calcium ATPaset type 2a (SERCA2a)) were measured. Morphological characteristics were studied with histology.ResultsWithout drugs to block HCN and RyR2 channels, there was prolongation of the AH interval, WBCL, and AVNERP (P v1.5, and RyR2 downregulate in the regions of the AVJ and connexin 40, SERCA2a, and Cav1.3 upregulate (P ConclusionHeterogeneous ion channel expression changes were observed in the AVJ with aging. For the first time, we have shown that HCN and RyR2 play an important role in AVN dysfunction with aging.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29288034 · DOI · PMC5934612

The role of calcium stores in long-term potentiation and synaptic tagging and capture in mouse hippocampus [2]

Research article Koek LA, Sanderson TM, Georgiou J, Collingridge GL · · 2024 · cited 12 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The roles of Ca2+-induced calcium release in synaptic plasticity and metaplasticity are poorly understood.
Closing excerpt
This article is part of a discussion meeting issue 'Long-term potentiation: 50 years on'.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (222 words)

The roles of Ca2+-induced calcium release in synaptic plasticity and metaplasticity are poorly understood. The present study has addressed the role of intracellular Ca2+ stores in long-term potentiation (LTP) and a form of heterosynaptic metaplasticity known as synaptic tagging and capture (STC) at CA1 synapses in mouse hippocampal slices. The effects of two compounds, ryanodine and cyclopiazonic acid (CPA), were examined on LTP induced by three distinct induction protocols: weak (w), compressed (c) and spaced (s) theta-burst stimulation (TBS). These compounds did not significantly affect LTP induced by the wTBS (one episode of TBS; 25 stimuli) or cTBS (three such episodes with a 10 s inter-episode interval (IEI); 75 stimuli) but substantially inhibited LTP induced by a sTBS (10 min IEI; 75 stimuli). Ryanodine and CPA also prevented a small heterosynaptic potentiation that was observed with the sTBS protocol. Interestingly, these compounds also prevented STC when present during either the sTBS or the subsequent wTBS, applied to an independent input. All of these effects of ryanodine and CPA were similar to that of a calcium-permeable AMPA receptor blocker. In conclusion, Ca2+ stores provide one way in which signals are propagated between synaptic inputs and, by virtue of their role in STC, may be involved in associative long-term memories. This article is part of a discussion meeting issue 'Long-term potentiation: 50 years on'.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 38853556 · DOI · PMC11343308

Identification of an amino-terminus determinant critical for ryanodine receptor/Ca2+ release channel function [3]

Research article Seidel M, de Meritens CR, Johnson L, Parthimos D, Bannister M, Thomas NL, et al. · · 2021 · cited 11 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
AimsThe cardiac ryanodine receptor (RyR2), which mediates intracellular Ca2+ release to trigger cardiomyocyte contraction, participates in development of acquired and inherited arrhythmogenic cardiac disease.
Closing excerpt
ConclusionThese results suggest that efficient N-terminus inter-subunit communication mediated by the β8-β9 loop may constitute a primary regulatory mechanism for both RyR2 channel activation and suppression.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (227 words)

AimsThe cardiac ryanodine receptor (RyR2), which mediates intracellular Ca2+ release to trigger cardiomyocyte contraction, participates in development of acquired and inherited arrhythmogenic cardiac disease. This study was undertaken to characterize the network of inter- and intra-subunit interactions regulating the activity of the RyR2 homotetramer.Methods and resultsWe use mutational investigations combined with biochemical assays to identify the peptide sequence bridging the β8 with β9 strand as the primary determinant mediating RyR2 N-terminus self-association. The negatively charged side chains of two aspartate residues (D179 and D180) within the β8-β9 loop are crucial for the N-terminal inter-subunit interaction. We also show that the RyR2 N-terminus domain interacts with the C-terminal channel pore region in a Ca2+-independent manner. The β8-β9 loop is required for efficient RyR2 subunit oligomerization but it is dispensable for N-terminus interaction with C-terminus. Deletion of the β8-β9 sequence produces unstable tetrameric channels with subdued intracellular Ca2+ mobilization implicating a role for this domain in channel opening. The arrhythmia-linked R176Q mutation within the β8-β9 loop decreases N-terminus tetramerization but does not affect RyR2 subunit tetramerization or the N-terminus interaction with C-terminus. RyR2R176Q is a characteristic hypersensitive channel displaying enhanced intracellular Ca2+ mobilization suggesting an additional role for the β8-β9 domain in channel closing.ConclusionThese results suggest that efficient N-terminus inter-subunit communication mediated by the β8-β9 loop may constitute a primary regulatory mechanism for both RyR2 channel activation and suppression.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 32077934 · DOI · PMC7898959

Ryanodine-1-Calstabin Complex Stabilizers in Antidoping Research: Synthesis, Metabolism, and Characterization [4]

Research article Möller T, Piper T, Thevis M · · 2026 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Awareness of new potential doping agents and the proactive implementation of detection methods are key aspects of preventive antidoping research.
Closing excerpt
The findings of this study will contribute to routine doping control analytical programs and allow for improving existing detection methods.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (176 words)

Awareness of new potential doping agents and the proactive implementation of detection methods are key aspects of preventive antidoping research. Ryanodine receptor-1-calstabin complex stabilizers (RYR-stabilizers) are a novel class of drug candidates for the treatment of various diseases associated with leaky Ca2+ channels in the cardiac or skeletal muscle. Also, intense physical activity was shown to transiently cause leakage of skeletal muscle Ca2+ channels, and RYR-stabilizers have been shown to restore normal activity and, thus, increase endurance performance. Consequently, such compounds are relevant targets in doping controls, and to date, in particular, compounds S107, JTV-519, ARM 036, and ARM 210 have been subject of antidoping research. In this study, ARM 036 and ARM 210 as well as the commercially available compounds S107 and JTV-519 were synthesized using a multistep approach. Subsequently, all compounds were investigated concerning their in vitro metabolic behavior, and various metabolites were identified. Selected metabolites were then chemically synthesized for comprehensive structure confirmation. The findings of this study will contribute to routine doping control analytical programs and allow for improving existing detection methods.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41454756 · DOI · PMC12743319

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article The pharmacology of ryanodine and related compounds [5]
    Sutko JL, Airey JA, Welch W, Ruest L · Pharmacol Rev · 1997 · cited 192 times (Europe PMC)
  • Research article Role of ryanodine receptors [6]
    Ogawa Y · Crit Rev Biochem Mol Biol · 1994 · cited 191 times (Europe PMC)
  • Research article Characterization of the effects of ryanodine, TTX, E-4031 and 4-AP on the sinoatrial and atrioventricular nodes [7]
    Nikmaram MR, Liu J, Abdelrahman M, Dobrzynski H, Boyett MR, Lei M · Prog Biophys Mol Biol · 2008 · cited 31 times (Europe PMC)
  • Research article Ryanodine-sensitive Ca2+ release mechanism in non-excitable cells (Review) [8]
    Ozawa T · Int J Mol Med · 2001 · cited 22 times (Europe PMC)
  • Research article Ryanodine Receptors for Drugs and Insecticides: An Overview [9]
    Sun Z, Xu H · Mini Rev Med Chem · 2019 · cited 18 times (Europe PMC)
  • Research article Towards the development of ryanoid insecticides with low mammalian toxicity [10]
    Usherwood PN, Vais H · Toxicol Lett · 1995 · cited 11 times (Europe PMC)

References

  1. Saeed Y, Temple IP, Borbas Z, Atkinson A, Yanni J, Maczewski M, et al.. Structural and functional remodeling of the atrioventricular node with aging in rats: The role of hyperpolarization-activated cyclic nucleotide-gated and ryanodine 2 channels. . 2018. PMID 29288034 · DOI · PMC5934612
  2. Koek LA, Sanderson TM, Georgiou J, Collingridge GL. The role of calcium stores in long-term potentiation and synaptic tagging and capture in mouse hippocampus. . 2024. PMID 38853556 · DOI · PMC11343308
  3. Seidel M, de Meritens CR, Johnson L, Parthimos D, Bannister M, Thomas NL, et al.. Identification of an amino-terminus determinant critical for ryanodine receptor/Ca2+ release channel function. . 2021. PMID 32077934 · DOI · PMC7898959
  4. Möller T, Piper T, Thevis M. Ryanodine-1-Calstabin Complex Stabilizers in Antidoping Research: Synthesis, Metabolism, and Characterization. . 2026. PMID 41454756 · DOI · PMC12743319
  5. Sutko JL, Airey JA, Welch W, Ruest L. The pharmacology of ryanodine and related compounds. Pharmacol Rev. 1997. PMID 9085309 · DOI
  6. Ogawa Y. Role of ryanodine receptors. Crit Rev Biochem Mol Biol. 1994. PMID 8001396 · DOI
  7. Nikmaram MR, Liu J, Abdelrahman M, Dobrzynski H, Boyett MR, Lei M. Characterization of the effects of ryanodine, TTX, E-4031 and 4-AP on the sinoatrial and atrioventricular nodes. Prog Biophys Mol Biol. 2008. PMID 17850852 · DOI
  8. Ozawa T. Ryanodine-sensitive Ca2+ release mechanism in non-excitable cells (Review). Int J Mol Med. 2001. PMID 11115603 · DOI
  9. Sun Z, Xu H. Ryanodine Receptors for Drugs and Insecticides: An Overview. Mini Rev Med Chem. 2019. PMID 29600763 · DOI
  10. Usherwood PN, Vais H. Towards the development of ryanoid insecticides with low mammalian toxicity. Toxicol Lett. 1995. PMID 8597061 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • AnastrozoleDrugs and Chemicals
  • LosartanDrugs and Chemicals
  • ValsartanDrugs and Chemicals
  • SunitinibDrugs and Chemicals
  • AtorvastatinDrugs and Chemicals
  • AcetazolamideDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

2,915
PubMed records on this heading
2%
published since 2020
63
review articles
0
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • AnastrozoleDrugs and Chemicals
  • LosartanDrugs and Chemicals
  • ValsartanDrugs and Chemicals
  • SunitinibDrugs and Chemicals
  • AtorvastatinDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support